Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies
The Danish drugmaker Novo Nordisk argues that semaglutide, the active ingredient in Ozempic and Wegovy, are too complex for ...
Roche CEO says antitrust regulators should block Catalent sale to Novo Foundation
Roche CEO opposes Novo Nordisk's acquisition of Catalent, citing concerns about competition in the pharmaceutical industry.
Yahoo Finance3m
Oral GLP-1 receptor agonist Rybelsus reduces risk of cardiovascular events in type 2 diabetes patients
Novo Nordisk’s oral semaglutide has been on the market under the name Rybelsus since 2019, but the semaglutide injectables, ...
US Medicaid programs say cost a key factor for weight-loss drug coverage, survey finds
Most U.S. states do not currently cover highly sought after weight-loss drugs from Novo Nordisk and Eli Lilly in their ...
September home sales drop to lowest level since 2010
Inventory was 23% higher from September 2023 last month, good news for home buyers as it gives consumers more properties to ...
The most successful new hires do these 3 things, say talent officers at Salesforce and American Express
From the first day of a new job, new employees should begin to think about what success at their new company looks like, says ...
CEO shares the make-or-break interview question he always asks: Candidates ‘don't get the job' if they answer wrong
Gary Shapiro, CEO of the Consumer Technology Association, always asks job candidates how soon they can start the role. Their answers are telling, he says.